These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38823472)

  • 1. Rynchopeterine inhibits the formation of hypertrophic scars by regulating the miR-21/HIF1AN axis.
    Zhao W; Ye J; Yang X; Wang J; Cong L; Zhang Q; Li J
    Exp Cell Res; 2024 Jul; 440(2):114114. PubMed ID: 38823472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.
    Mu S; Kang B; Zeng W; Sun Y; Yang F
    Mol Cell Biochem; 2016 May; 416(1-2):99-108. PubMed ID: 27075467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
    Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
    Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-145-5p attenuates hypertrophic scar via reducing Smad2/Smad3 expression.
    Shen W; Wang Y; Wang D; Zhou H; Zhang H; Li L
    Biochem Biophys Res Commun; 2020 Jan; 521(4):1042-1048. PubMed ID: 31732152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-9-5p inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting peroxisome proliferator-activated receptor β.
    Chai CY; Tai IC; Zhou R; Song J; Zhang C; Sun S
    Biol Open; 2020 Dec; 9(12):. PubMed ID: 33355167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the role of Hsa-miR-31-5p in hypertrophic scar formation and the mechanism.
    Wang X; Zhang Y; Jiang BH; Zhang Q; Zhou RP; Zhang L; Wang C
    Exp Cell Res; 2017 Dec; 361(2):201-209. PubMed ID: 29056521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1.
    Li Y; Zhang J; Zhang W; Liu Y; Li Y; Wang K; Zhang Y; Yang C; Li X; Shi J; Su L; Hu D
    J Mol Histol; 2017 Dec; 48(5-6):357-366. PubMed ID: 28884252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TRHDE-AS1 inhibit the scar fibroblasts proliferation via miR-181a-5p/PTEN axis.
    Wei Y; Wang T; Zhang N; Ma Y; Shi S; Zhang R; Zheng X; Zhao L
    J Mol Histol; 2021 Apr; 52(2):419-426. PubMed ID: 33675502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts.
    Li G; Zhou R; Zhang Q; Jiang B; Wu Q; Wang C
    Exp Cell Res; 2016 Jul; 345(1):93-9. PubMed ID: 27207585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-3613-3p inhibits hypertrophic scar formation by down-regulating arginine and glutamate-rich 1.
    Li L; Han W; Chen Y; Chen Y
    Mol Cell Biochem; 2021 Feb; 476(2):1025-1036. PubMed ID: 33165823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
    Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
    Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-519d inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting Sirtuin 7.
    Zhou X; Xie Y; Xiao H; Deng X; Wang Y; Jiang L; Liu C; Zhou R
    Biomed Pharmacother; 2018 Apr; 100():184-190. PubMed ID: 29428666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panax Notoginseng Saponins suppresses TRPM7 via the PI3K/AKT pathway to inhibit hypertrophic scar formation in vitro.
    Zhi Y; Wang H; Huang B; Yan G; Yan LZ; Zhang W; Zhang J
    Burns; 2021 Jun; 47(4):894-905. PubMed ID: 33143990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking the MIR155HG/miR-155 axis reduces CTGF-induced inflammatory cytokine production and α-SMA expression via upregulating AZGP1 in hypertrophic scar fibroblasts.
    Li Y; Xiao Y; Han Y; Zhu H; Han J; Wang H
    Cell Signal; 2024 Aug; 120():111202. PubMed ID: 38729323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA H19 promotes the proliferation, migration and invasion while inhibits apoptosis of hypertrophic scarring fibroblasts by targeting miR-3187-3p/GAB1 axis.
    Xiao M; Zou X; Li B; Zhang B
    Burns; 2021 May; 47(3):654-664. PubMed ID: 32888745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
    Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
    Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-141-3p-Functionalized Exosomes Loaded in Dissolvable Microneedle Arrays for Hypertrophic Scar Treatment.
    Meng S; Wei Q; Chen S; Liu X; Cui S; Huang Q; Chu Z; Ma K; Zhang W; Hu W; Li S; Wang Z; Tian L; Zhao Z; Li H; Fu X; Zhang C
    Small; 2024 Feb; 20(8):e2305374. PubMed ID: 37724002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K/AKT/mTOR pathway.
    Chen H; Xu K; Sun C; Gui S; Wu J; Wang S
    An Bras Dermatol; 2023; 98(1):26-35. PubMed ID: 36272879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway.
    Wu X; Li J; Yang X; Bai X; Shi J; Gao J; Li Y; Han S; Zhang Y; Han F; Liu Y; Li X; Wang K; Zhang J; Wang Z; Tao K; Hu D
    J Mol Histol; 2018 Aug; 49(4):377-387. PubMed ID: 29785488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfat exerts an anti-fibrotic effect on human hypertrophic scar via fetuin-A/ETV4 axis.
    Yu Q; Dai Q; Huang Z; Li C; Yan L; Fu X; Wang Q; Zhang Y; Cai L; Yang Z; Xiao R
    J Transl Med; 2023 Mar; 21(1):231. PubMed ID: 37004048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.